3 Tips for Avoiding Having to File a Budapest Treaty Declaration When Prosecuting Patent Applications on Biological Materials
From Algorithms to Approvals: Navigating AI in Drug and Biological Product Regulation
Personal Jurisdiction Over Foreign Companies that File an ANDA or aBLA in the U.S.
Federal Circuit Reverses Decision Finding Lack of Written Description for Patent Claiming a Pharmaceutical Composition Comprising the Two Active Ingredients in Entresto®
Amgen v. Sanofi Case on Enablement of Antibody Genus Claims Will be Heard at the Supreme Court; Cert Denied in Juno v. Kite
Regeneron Disclaims an Aflibercept Formulation Patent in Response to Celltrion PGR
PTAB Institutes a Second IPR on Rituxan®-related ’821 Patent
